Mizuho raises target for Cardinal Health stock to USD 280.00

Published on 10/26/2026 at 16:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Quarterly revenue rose 5.80 percent to USD 63.67 billion. Cardinal Health stock costs EUR 226.90 on October 26, 2026, 0.49 percent above Tradegate close.

Analyst target and results date

Mizuho raised its Cardinal Health target from USD 250.00 to USD 280.00 on October 20, 2026.
Quarterly revenue reached USD 63.67 billion, up 5.80 percent year over year.
Cardinal Health stock costs EUR 226.90 at Lang & Schwarz on October 26, 2026 at 4:04 p.m. CEST, 0.49 percent above the Tradegate close of October 23, 2026.
Cardinal Health is scheduled to announce first-quarter fiscal 2027 results on November 5, 2026.

Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

Mizuho raised its Cardinal Health target from USD 250.00 to USD 280.00 on October 20, 2026, while maintaining an outperform rating, according to MarketBeat. The target was 10.52 percent above the NYSE price of USD 253.34 at 11:09 a.m. ET on October 26, 2026. Cardinal Health stock was trading at EUR 226.90 at Lang & Schwarz on October 26, 2026 at 4:04 p.m. CEST, up 0.49 percent versus the Tradegate close of October 23, 2026 at EUR 225.80.

Quarterly revenue reaches USD 63.67 billion

Cardinal Health reported quarterly revenue of USD 63.67 billion, up 5.80 percent from the same period a year earlier. Adjusted earnings per share reached USD 2.91, compared with a consensus estimate of USD 2.42, a difference of USD 0.49, according to MarketBeat. The company set fiscal 2027 adjusted earnings-per-share guidance at USD 12.40 to USD 12.60.

Stock remains below its yearly high

The NYSE quote stood at USD 253.34 at 11:09 a.m. ET on October 26, 2026. That price was USD 5.87 below the 52-week high of USD 259.21 and USD 91.98 above the 52-week low of USD 161.36. The same quote carried a market capitalization of USD 58.7 billion and volume of 270,644 shares.

Valuation at 35.07 times earnings

Cardinal Health traded at a trailing price-to-earnings ratio of 35.07 on October 26, 2026. The next scheduled corporate date is November 5, 2026, when the company is due to announce first-quarter fiscal 2027 results, as listed by Financial Times.

Comparison with peers

Cardinal Health operates in healthcare distribution alongside McKesson and Cencora. McKesson traded at USD 997.67 with a price-to-earnings ratio of 26.72 and a market capitalization of USD 116.3 billion at 11:10 a.m. ET on October 26, 2026. Cencora traded at USD 333.70 with a price-to-earnings ratio of 24.82 and a market capitalization of USD 63.7 billion at 11:10 a.m. ET on the same date.

Target increase leaves a measurable gap

Mizuho's USD 280.00 target is USD 26.66 above the NYSE quote used for the calculation. The operating figures place the latest quarterly revenue and earnings per share alongside a fiscal 2027 earnings range, giving the November reporting date a clear numerical reference point.

The stock was trading at EUR 226.90 at Lang & Schwarz on October 26, 2026 at 4:04 p.m. CEST, 0.49 percent above the Tradegate close of October 23, 2026 at EUR 225.80. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.